Localized Adenocarcinoma of the Pancreas: The Rationale for Preoperative Chemoradiation

Localized Adenocarcinoma of the Pancreas: The Rationale for Preoperative Chemoradiation Jeffrey D. Wayne, Eddie K. Abdalla, Robert A. Wolff, Christopher H. Crane, Peter W.T. Pisters, Douglas B. Evans Oncologist 2002; 7: 34-45 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in gastrointestinal cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Define the radiologic (CT) criteria that determines whether a pancreatic neoplasm is surgically resectable, locally advanced, or metastatic. Explain why it is difficult to conduct clinical trials of adjuvant or neoadjuvant therapy in resectable pancreatic cancer. Review the advantages and disadvantages of preoperative versus postoperative adjuvant therapy for patients with pancreatic adenocarcinoma. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Feb. 14, 2002 Most Recent Review: Nov. 15, 2005* Most Recent Update: Apr. 9, 2003 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.